XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained Deficit
Treasury Stock
Accumulated Other Comprehensive Income
Balance at beginning of year (in shares) at Dec. 31, 2020   10,233,223        
Balance at beginning of year at Dec. 31, 2020 $ 155,248 $ 10,233 $ 180,609 $ (28,090) $ (9,015) $ 1,511
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,890)     (1,890)    
Foreign currency translation adjustment 168         168
Shares issued (in shares)   6,523        
Shares issued 0 $ 6 (6)      
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)   (303)        
Tax withholdings related to net share settlements of stock-based compensation awards     13   (13)  
Balance at end of period (in shares) at Mar. 31, 2021   10,239,443        
Balance at end of period at Mar. 31, 2021 153,526 $ 10,239 180,616 (29,980) (9,028) 1,679
Balance at beginning of year (in shares) at Dec. 31, 2020   10,233,223        
Balance at beginning of year at Dec. 31, 2020 155,248 $ 10,233 180,609 (28,090) (9,015) 1,511
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (204)          
Foreign currency translation adjustment 172          
Balance at end of period (in shares) at Sep. 30, 2021   10,252,769        
Balance at end of period at Sep. 30, 2021 168,685 $ 10,253 194,049 (28,294) (9,048) (1,725)
Balance at beginning of year (in shares) at Dec. 31, 2020   10,233,223        
Balance at beginning of year at Dec. 31, 2020 $ 155,248 $ 10,233 180,609 (28,090) (9,015) 1,511
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares) 0          
Balance at end of period (in shares) at Dec. 31, 2021 10,542,333 10,294,824        
Balance at end of period at Dec. 31, 2021 $ 165,769 $ 10,318 197,057 (33,142) (10,033) 1,569
Balance at beginning of year (in shares) at Mar. 31, 2021   10,239,443        
Balance at beginning of year at Mar. 31, 2021 153,526 $ 10,239 180,616 (29,980) (9,028) 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 461     461    
Foreign currency translation adjustment (171)         (171)
Shares issued (in shares)   12,383        
Shares issued 0 $ 12 (12)      
Balance at end of period (in shares) at Jun. 30, 2021   10,251,826        
Balance at end of period at Jun. 30, 2021 153,816 $ 10,251 180,604 (29,519) (9,028) 1,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 1,225     1,225    
Foreign currency translation adjustment 175         175
Equity consideration for purchase of business 4,194   4,194      
Capital contribution 9,233   9,233      
Shares issued (in shares)   1,355        
Shares issued 0 $ 2 (2)      
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)   (412)        
Tax withholdings related to net share settlements of stock-based compensation awards 0   20   (20) 0
Other 42         42
Balance at end of period (in shares) at Sep. 30, 2021   10,252,769        
Balance at end of period at Sep. 30, 2021 $ 168,685 $ 10,253 194,049 (28,294) (9,048) (1,725)
Balance at beginning of year (in shares) at Dec. 31, 2021 10,542,333 10,294,824        
Balance at beginning of year at Dec. 31, 2021 $ 165,769 $ 10,318 197,057 (33,142) (10,033) 1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,537)     (2,537)    
Foreign currency translation adjustment 171         171
Shares issued (in shares)   6,065        
Shares issued 0 $ 6 (6)      
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)   (889)        
Tax withholdings related to net share settlements of stock-based compensation awards 0   33   (33)  
Other (95)   (95)      
Balance at end of period (in shares) at Mar. 31, 2022   10,300,000        
Balance at end of period at Mar. 31, 2022 $ 163,308 $ 10,324 196,989 (35,679) (10,066) 1,740
Balance at beginning of year (in shares) at Dec. 31, 2021 10,542,333 10,294,824        
Balance at beginning of year at Dec. 31, 2021 $ 165,769 $ 10,318 197,057 (33,142) (10,033) 1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares) 0          
Balance at end of period (in shares) at Jun. 30, 2022   19,443,982        
Balance at end of period at Jun. 30, 2022 $ 541,828 $ 19,468 573,649 (40,394) (10,144) (751)
Balance at beginning of year (in shares) at Dec. 31, 2021 10,542,333 10,294,824        
Balance at beginning of year at Dec. 31, 2021 $ 165,769 $ 10,318 197,057 (33,142) (10,033) 1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 9,289          
Foreign currency translation adjustment $ (12,094)          
Repurchase of common stock (in shares) (54,089)          
Balance at end of period (in shares) at Sep. 30, 2022 19,712,137 19,400,005        
Balance at end of period at Sep. 30, 2022 $ 546,747 $ 19,424 574,176 (23,853) (12,475) (10,525)
Balance at beginning of year (in shares) at Mar. 31, 2022   10,300,000        
Balance at beginning of year at Mar. 31, 2022 163,308 $ 10,324 196,989 (35,679) (10,066) 1,740
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (4,715)     (4,715)    
Foreign currency translation adjustment (2,491)         (2,491)
Stock-based compensation 573   573      
Shares issued (in shares)   25,682        
Shares issued 0 $ 24 (24)      
Deemed consideration for reverse acquisition (in shares)   9,120,167        
Deemed consideration for reverse acquisition 351,491 $ 9,120 342,371      
Reclassification of issuable shares from earnout derivative liability 26,593   26,593      
Fair value adjustment of stock-based compensation awards 1,910   1,910      
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)   (1,867)        
Tax withholdings related to net share settlements of stock-based compensation awards (78)       (78)  
Settlement of related party obligations 5,276   5,276      
Other (39)   (39)      
Balance at end of period (in shares) at Jun. 30, 2022   19,443,982        
Balance at end of period at Jun. 30, 2022 541,828 $ 19,468 573,649 (40,394) (10,144) (751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 16,541     16,541    
Foreign currency translation adjustment (9,774)         (9,774)
Stock-based compensation 489   489      
Shares issued (in shares)   17,992        
Shares issued $ 0 $ 18 (18)      
Repurchase of common stock (in shares) (54,089) (54,089)        
Repurchase of common stock $ (1,940) $ (54) 54   (1,940)  
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)   (7,880)        
Tax withholdings related to net share settlements of stock-based compensation awards (391) $ (8) 8   (391)  
Other $ (6)   (6)      
Balance at end of period (in shares) at Sep. 30, 2022 19,712,137 19,400,005        
Balance at end of period at Sep. 30, 2022 $ 546,747 $ 19,424 $ 574,176 $ (23,853) $ (12,475) $ (10,525)